Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy

Neuromuscular Disorders

Volumn 20, Issue 1, 2010, Pages 44-48

  Sacconi, Sabrina ^a   Trevisson, Eva ^b   Salviati, Leonardo ^b   Aymé, Ségolène ^c   Rigal, Odile ^d   Garcia Redondo, Alberto ^e   Mancuso, Michelangelo ^f   Siciliano, Gabriele ^f   Tonin, Paola ^g   Angelini, Corrado ^b   Auré, Karine ^c   Lombès, Anne ^c   Desnuelle, Claude ^a  

^a CENTRE DE BIOCHIMIE   (France)

^b UNIVERSITY OF PADOVA   (Italy)

^c INSERM   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e Hospital Universitario   (Spain)

^f Department of Neurology ^*  (Italy)

^g Clinica Neurologica   (Italy)

Author keywords

Coenzyme Q10; Mitochondrial disease; Myopathy; Treatment

Indexed keywords

MITOCHONDRIAL DNA; UBIDECARENONE; UBIQUINONE; DRUG DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL MYOPATHY; MUSCLE LEVEL; PRIORITY JOURNAL; UBIDECARENONE DEFICIENCY; CLINICAL TRIAL; COHORT ANALYSIS; GENETICS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MUTATION; PHENOTYPE; PRESCHOOL CHILD; SKELETAL MUSCLE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIAL MYOPATHIES; MUSCLE, SKELETAL; MUTATION; PHENOTYPE; TREATMENT OUTCOME; UBIQUINONE; YOUNG ADULT;

EID: 74249105071     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.10.014     Document Type: Article

References (32)

1. Crane F.L., Sun I.L., and Sun E.E. The essential functions of coenzyme Q. Clin Investig 71 (1993) S55-S59
2. Montero R., Sanchez-Alcazar J.A., Briones P., et al. Analysis of coenzyme Q10 in muscle and fibroblasts for the diagnosis of CoQ10 deficiency syndromes. Clin Biochem 41 (2008) 697-700
3. Casarin A., Jimenez-Ortega J.C., Trevisson E., et al. Functional characterization of human COQ4, a gene required for coenzyme Q10 biosynthesis. Biochem Biophys Res Commun 372 (2008) 35-39
4. Fernandez-Ayala D.J., Lopez-Lluch G., Garcia-Valdes M., Arroyo A., and Navas P. Specificity of coenzyme Q10 for a balanced function of respiratory chain and endogenous ubiquinone biosynthesis in human cells. Biochim Biophys Acta 1706 (2005) 174-183
5. Ogasahara S., Engel A.G., Frens D., and Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 86 (1989) 2379-2382
6. Sobreira C., Hirano M., Shanske S., et al. Mitochondrial encephalomyopathy with coenzyme Q10 deficiency. Neurology 48 (1997) 1238-1243
7. Boitier E., Degoul F., Desguerre I., et al. A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency. J Neurol Sci 156 (1998) 41-46
8. Van Maldergem L., Trijbels F., DiMauro S., et al. Coenzyme Q-responsive Leigh's encephalopathy in two sisters. Ann Neurol 52 (2002) 750-754
9. Musumeci O., Naini A., Slonim A.E., et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 56 (2001) 849-855
10. Lamperti C., Naini A., Hirano M., et al. Cerebellar ataxia and coenzyme Q10 deficiency. Neurology 60 (2003) 1206-1208
11. Gironi M., Lamperti C., Nemni R., et al. Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency. Neurology 62 (2004) 818-820
12. Rotig A., Appelkvist E.L., Geromel V., et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356 (2000) 391-395
13. Salviati L., Sacconi S., Murer L., et al. Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology 65 (2005) 606-608
14. Quinzii C., Naini A., Salviati L., et al. A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 78 (2006) 345-349
15. Mollet J., Giurgea I., Schlemmer D., et al. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J Clin Invest 117 (2007) 765-772
16. Lopez L.C., Schuelke M., Quinzii C.M., et al. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am J Hum Genet 79 (2006) 1125-1129
17. Lagier-Tourenne C., Tazir M., Lopez L.C., et al. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 82 (2008) 661-672
18. Mollet J., Delahodde A., Serre V., et al. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 82 (2008) 623-630
19. Duncan A.J., Bitner-Glindzicz M., Meunier B., et al. A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. Am J Hum Genet 84 (2009) 558-566
20. Quinzii C.M., Kattah A.G., Naini A., et al. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64 (2005) 539-541
21. Gempel K., Topaloglu H., Talim B., et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 130 (2007) 2037-2044
22. Aeby A., Sznajer Y., Cave H., et al. Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency. J Inherit Metab Dis 30 (2007) 827
23. Montero R., Sanchez-Alcazar J.A., Briones P., et al. Coenzyme Q10 deficiency associated with a mitochondrial DNA depletion syndrome: a case report. Clin Biochem 42 (2009) 742-745
24. Montini G., Malaventura C., and Salviati L. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med 358 (2008) 2849-2850
25. Chinnery P., Majamaa K., Turnbull D., and Thorburn D. Treatment for mitochondrial disorders. Cochrane Database Syst Rev (2006) CD004426
26. Benoist J.F., Rigal O., Nivoche Y., Martin C., Biou D., and Lombes A. Differences in coenzyme Q10 content in deltoid and quadriceps muscles. Clin Chim Acta 329 (2003) 147-148
27. Quinzii C.M., DiMauro S., and Hirano M. Human coenzyme Q10 deficiency. Neurochem Res 32 (2007) 723-727
28. Sano Y., Date H., Igarashi S., et al. Aprataxin, the causative protein for EAOH is a nuclear protein with a potential role as a DNA repair protein. Ann Neurol 55 (2004) 241-249
29. Folkers K., Vadhanavikit S., and Mortensen S.A. Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10. Proc Natl Acad Sci USA 82 (1985) 901-904
30. Muller T., Buttner T., Gholipour A.F., and Kuhn W. Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease. Neurosci Lett 341 (2003) 201-204
31. Miles M.V., Miles L., Tang P.H., et al. Systematic evaluation of muscle coenzyme Q10 content in children with mitochondrial respiratory chain enzyme deficiencies. Mitochondrion 8 (2008) 170-180
32. Montero R., Artuch R., Briones P., et al. Muscle coenzyme Q10 concentrations in patients with probable and definite diagnosis of respiratory chain disorders. Biofactors 25 (2005) 109-115